皮内注射市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00019998
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 197
Buy Now

皮内注射市場は、2021 年の 35 億 1,326 万米ドルから 2028 年までに 74 億 1,570 万米ドルに達すると予測されており、2021 年から 2028 年までの CAGR は 11.3% になると予想されています。



世界保健機関(WHO) は、医療提供における無駄の削減が、医療システムを強化する重要な側面であると認識しています。技術の進歩は、無駄を最小限に抑え、利用可能なリソースでより良い結果を達成する外科的アプローチの開発につながりました.再利用可能な皮内デバイスは、廃棄物の発生を抑えるアプローチの 1 つであり、経済の生産性に正味のプラスの効果をもたらします。これに加えて、いくつかのメタ分析の結果は、最適な応答を達成するために必要な薬物の濃度が比較的低いため、薬物の皮内送達が有害事象の強度を軽減できることも実証しました。上記の要因は、将来的にこのセグメントが急速に成長するための好ましい条件を示しています。



過去 20 年間、さまざまな疾患の発生率の上昇により、皮内注射の需要が前例のないほど急増しています。皮内ワクチン接種と美容処置の受け入れの増加。さらに、皮内ジェット注射器、マイクロインジェクション、および弾道皮内注射などの侵襲性の低い皮内デバイスの需要も、治療および診断目的で人口の間で高まっています。 WHO のデータによると、結核は 13 の主要な死因であり、毎年約 1,000 万件の結核患者が記録されており、結核の診断率が急激に上昇しています。過去 10 年間、ツベルクリン注射器の皮内注射の市場規模を拡大する主な理由の 1 つとして機能します。さらに、美容処置の数は北米とヨーロッパで急速に増加しています。



戦略的洞察



さらに、皮内インフルエンザワクチン、肝炎ワクチン、および天然痘ワクチンの利用可能性は、皮内注射市場;また、さまざまな企業の臨床パイプラインで COVID-19 皮内ワクチンが利用可能になったことで、この市場の成長率がさらに高まると予想されます。ここ数年、皮内ワクチンの需要が急増しており、さまざまな大手メーカーが皮内注射シミュレーターとトレーニング モデルを導入して、学生や医療専門家のスキルを向上させ、エラーの可能性を最小限に抑えています。したがって、皮内感染の有効性は継続的に増加しており、このセグメントの明るい未来を示しています。皮内注射および美容処置の採用が拡大し、皮内注射市場を牽引

皮内ワクチン接種は、抗原の潜在的な投与量を減らし、ワクチンによって生成される免疫応答を改善し、それに伴う不安を軽減します。予防接種。この方法は、従来のワクチン接種と比較して有害事象の可能性が低いため、併存疾患のある困難な集団グループにワクチン接種することもできます。さらに、神経毒関連の審美的処置は局所的な美容処置の主要なセグメントであり、皮内注射は主にさまざまな神経毒を送達するために使用され、最終的に皮内注射の需要を増加させます。結核の有病率の上昇も、皮内注射市場の成長率を促進すると予想されます。



方法に基づく洞察



方法に基づいて、皮内注射市場はさらに次のように分割されます。普通針、短針、無針。短い針は、皮内マイクロインジェクション、マイクロニードル アレイ、およびタトゥー デバイスにさらにサブセグメント化されますが、針のないものは、皮内液体ジェット インジェクターと弾道皮内インジェクターにサブセグメント化されます。 2021 年には、通常サイズの針が市場を独占しましたが、2021 年から 2028 年にかけて、短い針セグメントが最高の CAGR を記録すると推定されています。



方法別の皮内注射市場 - 2021 年と 2028 年



< p>(画像) アプリケーションベースの洞察



アプリケーションに基づいて、市場はツベルクリン皮膚検査、アレルギー検査、局所美学などに分割されます。ツベルクリン皮膚検査セグメントは、2021 年に市場で最大のシェアを保持すると推定されていますが、ローカル美容セグメントは、予測期間中に最高の CAGR を記録すると予想されます。



皮内注射市場で事業を行っている企業は、世界中で進化する顧客の要求を満たすために製品革新の戦略を採用することについて。



皮内注射市場 - セグメンテーション



製品タイプに基づいて、皮内注射市場は通常サイズの針、短い針、針なしに分割されます。短い針は、皮内マイクロインジェクション、マイクロニードル アレイ、およびタトゥー デバイスにさらにサブセグメント化されますが、針のないものは、皮内液体ジェット インジェクターと弾道皮内インジェクターにサブセグメント化されます。アプリケーションに基づいて、皮内注射市場は、ツベルクリン皮膚検査、アレルギー検査、局所美学などに分割されます。エンドユーザーによって、除細動器市場は病院、診断研究所、学者および研究機関などに分割されます。地域別では、皮内注射市場は北米 (米国、カナダ、メキシコ)、ヨーロッパ (フランス、ドイツ、イタリア、英国、スペイン、その他のヨーロッパ)、アジア太平洋 (オーストラリア、中国、インド) に分割されています。 、日本、韓国、およびその他の APAC)、中東およびアフリカ (サウジアラビア、南アフリカ、UAE、およびその他の MEA)、および中南米 (ブラジル、アルゼンチン、およびその他の SCAM) .



Becton Dickinson、Cardinal Health、West Pharmaceuticals services、Terumo Corporation、Nanopass、Pharmajet、Idevax、Enusung、Crossject、および Hindustan Syringes and Medical Devices は、皮内注射市場で事業を行っている主要企業の 1 つです。< /p>

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which is the most influencing segment growing in the intradermal injection market report?

The global intradermal injection market based on method is segmented into normal-sized needles, short needles and without needles. In 2021, the normal sized needles segment held the largest share of the market, by method while the short needle segment is expected to witness fastest CAGR during 2021 to 2028, due to its increasing acceptance among the global population.

What is the market value of intradermal injection market based on region?

The global intradermal injection market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The North American area holds the largest market for intradermal injection. The United States held the most significant intradermal injection market and is expected to grow due to factors such as the increasing diagnostic rates, intradermal vaccination and cosmetic surgeries while the technological advancements by key players in intradermal injections is also boosting the growth rate in US.
The Asia Pacific region is expected to account for the fastest growth in the intradermal injection market. In Japan, India and South Korea, the market is expected to grow owing to the development of the healthcare systems and proliferating medical tourism.

What are the factors impacting for the intradermal injection market?

Several factors are believed to affect intradermal injection market in the coming years. Factors such as growing adoption of intradermal vaccination, increasing incidence of various communicable and non-communicable diseases and increasing acceptance of aesthetic procedures are driving the market growth. However, risks, complications and dosing limitation associated with intradermal injections are likely to hamper the growth of the market.

Who are the major players in the intradermal injection market?

The intradermal injection market majorly consists of the players such as Becton Dickinson, Cardinal Health, West Pharmaceuticals services, Terumo Corporation, Nanopass, Pharmajet, Idevax, Enusung, Crossject, Hindustan Syringes and Medical Devices and others.

What is intradermal injection?

Intradermal injections are the devices used for delivering the active ingredients to the dermis layer of skin. These devices are mainly used for exerting a local action or minimal systemic action, which is mainly due to the limited presence of blood vessels in the dermis layer. The advantages of intradermal injections such as less pain, reduction in adverse events and accurate dose delivery etc. are mainly responsible for its rising market penetration while innovation in this sectors such as needle free intradermal delivery is expected to increase its adaptation rate at global level.

The List of Companies - Intradermal injection Market

  1. BD
  2. West Pharmaceuticals Services
  3. Terumo Corporation
  4. Nanopass
  5. Pharmajet
  6. Idevax
  7. Ensung Global
  8. Crossject
  9. Cardinal Health
  10. Hindustan Syringes and Medical Devices

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports